Kunin-Lunenfeld Applied Research Unit, Baycrest Center, Toronto, Ontario, Canada.
Am J Geriatr Psychiatry. 2011 Sep;19(9):803-13. doi: 10.1097/JGP.0b013e3181ff67a1.
Cholinesterase inhibitors (ChEIs) may interact with muscle relaxants given during general anesthesia (GA), increasing the risk of postoperative complications. We evaluated the effects of ChEIs on the postoperative outcomes of older adults who underwent hip fracture surgery.
Population-based cohort study using linked administrative databases.
All individuals with dementia age 66 years or older, who underwent hip fracture surgery between April 1, 2003, and December 31, 2007, in Ontario, Canada.
Use of any ChEI (donepezil, rivastigmine, or galantamine) before surgery.
The primary composite outcome included any of the following: 30-day postoperative mortality; intensive care unit admissions; or in-hospital resuscitation. Secondary outcomes included postoperative respiratory failure and pneumonia.
We stratified the study sample on the basis of residence (community or long-term care [LTC]) and type of anesthetic (general or regional) to create four residence/anesthesia groups. We used propensity scores to match users and nonusers of ChEIs within the residence/anesthesia strata. We then calculated the relative risks (RR) and 95% confidence intervals (CI) for outcomes associated with ChEIs in the matched groups.
A total of 624 pairs of individuals from the community and 725 pairs from LTC were created among individuals who received GA. High rates of postoperative mortality and complications were observed in both ChEI users and nonusers. The RR of the primary outcome associated with ChEI use for individuals receiving GA was 0.88 (95% CI: 0.68-1.16; χ2 = 0.93; df = 1; p = 0.34) and 0.82 (95% CI: 0.63-1.04; χ2 = 2.59; df = 1; p = 0.11) in the community and LTC groups, respectively. In addition, ChEIs were not associated with any significant increased risk of postoperative respiratory complications.
ChEI use was not associated with an increased risk of postoperative complications among older adults with dementia who underwent hip fracture surgery. However, the poor postoperative outcomes overall reinforced the need to prevent fractures and improve outcomes in this population.
胆碱酯酶抑制剂(ChEIs)可能会与全身麻醉(GA)期间给予的肌肉松弛剂相互作用,增加术后并发症的风险。我们评估了 ChEIs 对接受髋关节骨折手术的老年患者术后结局的影响。
基于人群的队列研究,使用关联的行政数据库。
所有年龄在 66 岁或以上、2003 年 4 月 1 日至 2007 年 12 月 31 日期间在加拿大安大略省接受髋关节骨折手术且患有痴呆症的个体。
手术前使用任何 ChEI(多奈哌齐、利斯的明或加兰他敏)。
主要复合结局包括以下任何一种情况:术后 30 天死亡率;重症监护病房入院;或院内复苏。次要结局包括术后呼吸衰竭和肺炎。
我们根据居住地(社区或长期护理[LTC])和麻醉类型(全身或区域)对研究样本进行分层,创建了四个居住/麻醉组。我们使用倾向评分在居住/麻醉分层内匹配 ChEI 使用者和非使用者。然后,我们计算了在匹配组中与 ChEI 相关的结局的相对风险(RR)和 95%置信区间(CI)。
在接受 GA 的个体中,从社区创建了 624 对 ChEI 使用者和非使用者,从 LTC 创建了 725 对。在 ChEI 使用者和非使用者中,均观察到较高的术后死亡率和并发症发生率。接受 GA 的个体中,与 ChEI 使用相关的主要结局的 RR 为 0.88(95%CI:0.68-1.16;χ2=0.93;df=1;p=0.34)和 0.82(95%CI:0.63-1.04;χ2=2.59;df=1;p=0.11),分别在社区和 LTC 组中。此外,ChEI 与术后呼吸并发症的任何显著增加风险无关。
在接受髋关节骨折手术的老年痴呆症患者中,ChEI 使用与术后并发症风险增加无关。然而,整体较差的术后结局强调了在该人群中预防骨折和改善结局的必要性。